Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jiyuan Ma, Qing Ye, Valerie Northcutt, John Babiak & Ronald Kong. (2022) Absorption, distribution, metabolism and excretion of 14C-Emvododstat following a single oral dose in rats and dogs. Xenobiotica 52:12, pages 1031-1040.
Read now
Read now
Articles from other publishers (5)
Huan Yang, XiaQing Cai, MeiJia Qiu, ChengChen Deng, HongYan Xue, JiaoJiao Zhang, Weirong Yang & Wang XianZhong. (2024) Heat stress induces ferroptosis of porcine Sertoli cells by enhancing CYP2C9-Ras- JNK axis. Theriogenology 215, pages 281-289.
Crossref
Crossref
Jiyuan Ma, Oscar L. Laskin, Ad F. Roffel, Wouter H.J. Vaes, Bowen Tang, Jeroen Kolnaar, Kylie O’Keefe, Lee Golden & Ronald Kong. (2024)
Absorption, Metabolism, and Excretion of
14
C-Emvododstat Following Repeat Daily Oral Dose Administration in Human Volunteers Using a Combination of Microtracer Radioactivity and High-Radioactivity Doses
. Drug Metabolism and Disposition 52:1, pages 26-34.
Crossref
Crossref
Terri L. Morton, Oscar L. Laskin, Diksha Kaushik, Lucy Lee, Jiyuan Ma, Cristian M. Bar, Allan Kristensen, Kylie O’Keefe, Lee Golden, Matthew Klein & Ronald Kong. (2023) A clinical pharmacokinetic drug-drug interaction study between dextromethorphan and emvododstat, a potent anti-SARS-CoV-2 dihydroorotate dehydrogenase inhibitor. European Journal of Clinical Pharmacology 79:8, pages 1073-1080.
Crossref
Crossref
Terri L. Morton, Oscar L. Laskin, Diksha Kaushik, Lucy Lee, Jiyuan Ma, Allan Kristensen, Kylie O'Keefe, Lee Golden, Matthew Klein & Ronald Kong. (2023)
A pharmacokinetic drug–drug interaction study between rosuvastatin and emvododstat, a potent
anti‐SARS‐CoV
‐2 (
COVID
‐19)
DHODH
(dihydroorotate dehydrogenase) inhibitor
. Pharmacology Research & Perspectives 11:2.
Crossref
Crossref
Lucy Lee, Katsuyuki Murase, Jiyuan Ma & Martin Thoolen. (2022) Clinical Drug‐Drug Interaction Between Vatiquinone, a 15‐Lipoxygenase Inhibitor, and Rosuvastatin, a Breast Cancer Resistance Protein Substrate. Clinical Pharmacology in Drug Development 12:3, pages 279-286.
Crossref
Crossref